Ariel Perez Perez

CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma

Kai Rejeski, Ariel Perez Perez, Pierre Sesques et al. · Blood · 2021 · 398 citations · Full text

The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL

Kai Rejeski, Ariel Perez Perez, Gloria Iacoboni et al. · Journal for ImmunoTherapy of Cancer · 2022 · 169 citations · Full text

Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion

Kai Rejeski, Ariel Perez Perez, Gloria Iacoboni et al. · Science Advances · 2023 · 54 citations · Full text

T Cell Therapy, T-regulatory Cell, Immunology +19

Increased Infections and Delayed CD4+ T Cell but Faster B Cell Immune Reconstitution after Post-Transplantation Cyclophosphamide Compared to Conventional GVHD Prophylaxis in Allogeneic Transplantation

Farhad Khimani, Peter Ranspach, Hany Elmariah et al. · Transplantation and Cellular Therapy · 2021 · 44 citations

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

Veit Bücklein, Ariel Perez Perez, Kai Rejeski et al. · HemaSphere · 2023 · 32 citations · Full text